Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADELE: Microbial Exposure and Immune Response
NCT03351543Phase 1Completed
- Sponsor
- University of Helsinki
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in immune system disorders (2 arms), sponsored by University of Helsinki. Primary endpoints: blood serum cytokine levels, blood serum IgE levels and 1 more. Started Mar 2016; status: completed.
02
Conditions
immune system disorders
Beyond the preview
Go deeper on NCT03351543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03351543.